These results, together with a past report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 assistance the strategy of targeting ACKR3 as a unique way to modulate the opioid technique, which could open new therapeutic avenues for opioid-relevant Conditions.A analysis study released in Anesthesiology and